FDA Approved: KENGREAL — Original Application (Chiesi USA, Inc.)

View source ↗

Summary

The FDA approved KENGREAL (cangrelor) in its original application from Chiesi USA, Inc., authorizing its use as an intravenous antiplatelet agent to reduce peri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Kengreal (cangrelor)

Snippet

ORIG AP for KENGREAL (CANGRELOR)